We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$44.9B
AUM Growth
+$4.18B
Cap. Flow
+$1.06B
Cap. Flow %
2.37%
Top 10 Hldgs %
17.28%
Holding
2,386
New
190
Increased
819
Reduced
1,044
Closed
186

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$237M
2
PFE icon
Pfizer
PFE
+$231M
3
AMGN icon
Amgen
AMGN
+$181M
4
CSCO icon
Cisco
CSCO
+$179M
5
NBIS
Nebius Group N.V.
NBIS
+$159M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$288M
2
UPS icon
United Parcel Service
UPS
+$251M
3
KO icon
Coca-Cola
KO
+$134M
4
T icon
AT&T
T
+$111M
5
VEEV icon
Veeva Systems
VEEV
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 15.27%
3 Financials 11.35%
4 Consumer Discretionary 10.6%
5 Communication Services 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
2151
X4 Pharmaceuticals
XFOR
$377M
0
XOMA
2152
DELISTED
Xoma
XOMA
$1K ﹤0.01%
+10
New +$224
ONIT
2153
Onity Group
ONIT
$342M
$1K ﹤0.01%
67
+27
+68% +$653
MAGN
2154
Magnera Corp
MAGN
$493M
0
PVLA
2155
Palvella Therapeutics
PVLA
$2.05B
-404
Closed -$112K
ENZ
2156
DELISTED
Enzo Biochem, Inc.
ENZ
$1K ﹤0.01%
297
CNSL
2157
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$1K ﹤0.01%
147
-112
-43% -$430
CHUY
2158
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$1K ﹤0.01%
14
-5
-26% -$130
ASXC
2159
DELISTED
Asensus Surgical, Inc.
ASXC
$1K ﹤0.01%
+568
New +$1.97K
KAMN
2160
DELISTED
Kaman Corp
KAMN
$1K ﹤0.01%
1
-10
-91% -$625
KRTX
2161
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1K ﹤0.01%
+2
New +$88
SUNW
2162
DELISTED
Sunworks, Inc.
SUNW
$1K ﹤0.01%
60
+28
+88% +$52
VMW
2163
DELISTED
VMware, Inc
VMW
$1K ﹤0.01%
7
-3
-30% -$470
HCCI
2164
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$1K ﹤0.01%
+4
New +$114
ACGN
2165
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
6
-12
-67% -$446
TDW.WS.A
2166
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
0
TDW.WS.B
2167
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
0
TCFC
2168
DELISTED
The Community Financial Corporation Common Stock
TCFC
$1K ﹤0.01%
1
-33
-97% -$1.12K
APTX
2169
DELISTED
Aptinyx Inc. Common Stock
APTX
$1K ﹤0.01%
386
-916
-70% -$3.15K
ELVT
2170
DELISTED
Elevate Credit, Inc.
ELVT
$1K ﹤0.01%
136
IVC
2171
DELISTED
Invacare Corporation
IVC
$1K ﹤0.01%
+53
New +$446
CHRA
2172
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$1K ﹤0.01%
+2
New +$42
EMWP
2173
DELISTED
Eros Media World PLC
EMWP
$1K ﹤0.01%
1
-1
-50% -$47
BDR
2174
DELISTED
Blonder Tongue Laboratories Inc
BDR
$1K ﹤0.01%
909
ATRS
2175
DELISTED
Antares Pharma, Inc.
ATRS
$1K ﹤0.01%
+80
New +$327

Similar funds

Federated Hermes's Q4 2019 Portfolio in Review

As of Q4 2019, Federated Hermes held 2,386 positions worth $44.9B, up 10% from $40.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Federated Hermes's Q4 2019 filing shows 190 new, 819 increased, 1,044 reduced and 186 closed positions. Its largest new stake was Nebius Group N.V.: 4,250,752 shares worth $185M. The largest sale was PepsiCo, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q4 2019 buy was Nebius Group N.V.: 4,250,752 shares worth $185M.
  • Federated Hermes added most to Alibaba in Q4 2019, an estimated $237M increase.
  • Federated Hermes's biggest Q4 2019 reduction was PepsiCo, cutting an estimated $288M.
  • Federated Hermes fully exited Trip.com Group in Q4 2019, selling an estimated $79.8M.
  • Federated Hermes's ten largest holdings make up 17% of its $44.9B portfolio in Q4 2019.
  • Federated Hermes opened 190 new positions and closed 186 in Q4 2019.
  • Federated Hermes's portfolio value rose 10% quarter-over-quarter to $44.9B.

Based on Federated Hermes's 13F filing for Q4 2019, filed 14 Feb 2020.